India-based Arch Pharmalabs has entered into a strategic partnership with Orochem Technologies, to manufacture a US company?s active pharmaceutical ingredient (API) in late-stage clinical development using simulated moving bed (SMB) chromatography.
India-based Arch Pharmalabs has entered into a strategic partnership with Orochem Technologies, to manufacture a US company’s active pharmaceutical ingredient (API) in late-stage clinical development using simulated moving bed (SMB) chromatography.
Arch Pharmalabs provides small molecule process R&D and full life-cycle custom synthesis and manufacturing services, while Orochem Technologies manufactures SMB equipment and stationary chromatography phases for bioanalytical, solid-phase extraction, flash and preparative applications. The collaboration marks the first time that plant-scale SMB has been used to manufacture an API in India.
